funder-graph

FundersDCGo2 for Lung Cancer › 2022

Grants paid by Go2 for Lung Cancer, tax year 2022

EIN 20-4417327 · Washington, DC · Form 990, Schedule I · NTEE G12

In tax year 2022, Go2 for Lung Cancer (EIN 20-4417327) reported 8 grants paid totaling $1,716,780. Dataset version 2026.09.0, built 2026-09-03.

20202021202220232024

Every grant, 2022

Grants reported by Go2 for Lung Cancer for tax year 2022
Tax yearRecipientMatchAmountTypePurposeSource filing
2022Memorial Health System Foundation Boston, MAA$680,000paidPatient support202332779349301133
2022Addario Lung Cancer Medical Institute San Carlos, CAA$600,000paidResearch202332779349301133
2022University of Alabama at Birmingham Birmingham, ALA$175,000paidResearch202332779349301133
2022Vanderbilt University Medical Center Nashville, TNA$175,000paidResearch202332779349301133
2022Iaslc Aurora, COA$28,125paidResearch202332779349301133
2022Physicians Education Resource Plainsboro, NJA$25,000paidResearch202332779349301133
2022Dana Farber Cancer Institute Boston, MAA$25,000paidResearch202332779349301133
2022Alk Positive Inc Atlanta, GAA$8,655paidResearch202332779349301133

Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.

Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.

Derived from IRS Form 990 e-file XML. Dataset version 2026.09.0, built 2026-09-03. All years for this funder.

The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.

This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.